Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

被引：2
|
作者：
Thomas, Xavier
Rijneveld, Anita W.
Fracchiolla, Nicola
Salek, Cyril
Spyridonidis, Alexandros
Chiaretti, Sabina
Alam, Naufil
Grueter, Isabella Pezzani
Mohammad, Abeera
Kormany, William
Kreuzbauer, Georg
Rambaldi, Alessandro
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study
    Nicolas Boissel
    Sabina Chiaretti
    Cristina Papayannidis
    Josep-Maria Ribera
    Renato Bassan
    Andrey N. Sokolov
    Naufil Alam
    Alessandra Brescianini
    Isabella Pezzani
    Georg Kreuzbauer
    Gerhard Zugmaier
    Robin Foà
    Alessandro Rambaldi
    Blood Cancer Journal, 13
  • [42] Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study
    Boissel, Nicolas
    Chiaretti, Sabina
    Papayannidis, Cristina
    Ribera, Josep-Maria
    Bassan, Renato
    Sokolov, Andrey N.
    Alam, Naufil
    Brescianini, Alessandra
    Pezzani, Isabella
    Kreuzbauer, Georg
    Zugmaier, Gerhard
    Foa, Robin
    Rambaldi, Alessandro
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [43] High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
    Cabannes-Hamy, Aurelie
    Brissot, Eolia
    Leguay, Thibaut
    Huguet, Francoise
    Chevallier, Patrice
    Hunault, Mathilde
    Escoffre-Barbe, Martine
    Cluzeau, Thomas
    Balsat, Marie
    Nguyen, Stephanie
    Pasquier, Florence
    Alexis, Magda
    Lheritier, Veronique
    Pastoret, Cedric
    Delabesse, Eric
    Clappier, Emmanuelle
    Dombret, Herve
    Boissel, Nicolas
    HAEMATOLOGICA, 2022, 107 (09) : 2072 - 2080
  • [44] Real-World Treatment of Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Using Tisagenlecleucel That Is out of Specification for Commercial Release
    Rossoff, Jenna
    Baggott, Christina
    Prabhu, Snehit
    Pacenta, Holly
    Phillips, Christine L.
    Stefanski, Heather
    Talano, Julie-An
    Moskop, Amy
    Margossian, Steven P.
    Verneris, Michael R.
    Myers, Gary Douglas
    Karras, Nicole
    Brown, Patrick A.
    Qayed, Muna
    Hermiston, Michelle
    Satwani, Prakash
    Krupski, Christa
    Keating, Amy
    Wilcox, Rachel
    Rabik, Cara A.
    Fabrizio, Vanessa
    Kunicki, Michael
    Chinnabhandar, Vasant
    Goksenin, A. Yasemin
    Curran, Kevin J.
    Mackall, Crystal L.
    Laetsch, Theodore W.
    Schultz, Liora M.
    BLOOD, 2020, 136
  • [45] Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
    Chevallier, Patrice
    Leguay, Thibaut
    Delord, Marc
    Salek, Cyril
    Kim, Rathana
    Huguet, Francoise
    Hicheri, Yosr
    Wartiovaara-Kautto, Ulla
    Raffoux, Emmanuel
    Cluzeau, Thomas
    Balsat, Marie
    Roth-Guepin, Gabrielle
    Tavernier, Emmanuelle
    Lepretre, Stephane
    Bilger, Karin
    Bergugnat, Hugo
    Berceanu, Ana
    Alexis, Magda
    Doubek, Michael
    Brissot, Eolia
    Hunault-Berger, Mathilde
    Lebon, Delphine
    Turlure, Pascal
    Chantepie, Sylvain
    Belhabri, Amine
    Wickenhauser, Stefan
    Bastie, Jean-Noel
    Cacheux, Victoria
    Himberlin, Chantal
    Banos, Anne
    Gardin, Claude
    Bonnet, Sarah
    Plantier, Isabelle
    Pica, Gian Matteo
    Escoffre-Barbe, Martine
    Boissel, Nicolas
    Dombret, Herve
    Clappier, Emmanuelle
    Rousselot, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (36)
  • [46] Updated Results from a Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Ravandi, Farhad
    Huang, Xuelin
    Jain, Nitin
    Kadia, Tapan M.
    Khoury, Joseph D.
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Alvarado, Yesid
    Burger, Jan A.
    Daver, Naval
    Borthakur, Gautam
    DiNardo, Courtney D.
    Konopleva, Marina
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    Wierda, William G.
    Kornblau, Steven M.
    Jacob, Jovitta
    Kwari, Monica
    Rausch, Caitlin R.
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Garris, Rebecca
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2021, 138
  • [47] Efficacy and safety blinatumomab in chinese adults with Ph-negative relapsed/refractory B-cell Precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study
    Zhou, Hongsheng
    Yin, Qingsong
    Jin, Jie
    Liu, Ting
    Cai, Zhen
    Jiang, Bin
    Li, Dengju
    Sun, Zimin
    Li, Yan
    He, Yanjuan
    Ma, Liping
    Gao, Sujun
    Hu, Jianda
    He, Aili
    Du, Xin
    Liu, Daihong
    Zhang, Xiaohong
    Ke, Xiaoyan
    Zhuang, Junling
    Han, Yue
    Wang, Xiaoqin
    Chen, Yuqi
    Gordon, Paul
    Yu, Dong
    Zugmaier, Gerhard
    Wang, Jianxiang
    HEMATOLOGY, 2022, 27 (01) : 917 - 927
  • [48] A Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Updated Results and Predictors for Outcomes
    Nasnas, Patrice
    Jabbour, Elias
    Short, Nicholas
    Ravandi, Farhad
    Huang, Xuelin
    Jain, Nitin
    Kadia, Tapan M.
    Alvarado, Yesid
    Burger, Jan A.
    Daver, Naval
    Borthakur, Gautam
    DiNardo, Courtney D.
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Wierda, William G.
    Jacob, Jovitta
    Deen, Wuliamatu
    Kwari, Monica
    Loiselle, Christopher
    Roy, Edith
    Milton, Anna
    Rivera, Juan
    Garris, Rebecca
    Kantarjian, Hagop
    BLOOD, 2022, 140 : 11679 - 11682
  • [49] Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study
    Lu, Jing
    Wang, Ying
    Qiu, Huiying
    Zhou, Xin
    Lu, Xuzhang
    Miao, Miao
    Gu, Bin
    Hu, Xiaohui
    Wu, Depei
    Chen, Suning
    BLOOD, 2023, 142
  • [50] EORTC-8D UTILITY VALUES IN PATIENTS WITH PHILADELPHIA NEGATIVE (PH-) RELAPSED/REFRACTORY (R/R) B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-CELL ALL) RECEIVING BLINATUMOMAB VERSUS STANDARD OF CARE (SOC) CHEMOTHERAPY IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)
    Hagiwara, M.
    Delea, T. E.
    Cong, Z.
    Franklin, J.
    Zimmerman, Z.
    VALUE IN HEALTH, 2017, 20 (05) : A123 - A123
12345